Krishnamurthy Nirup 4
4 · Medicine Man Technologies, Inc. · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Krishnamurthy Nirup
Chief Operating Officer
Transactions
- Purchase
Common Stock
2023-11-21$0.61/sh+10,000$6,141→ 1,610,000 total - Purchase
Common Stock
2023-11-29$0.59/sh+6,600$3,893→ 1,616,600 total
Footnotes (2)
- [F1]Issued as restricted stock units (RSUs) in connection with reporting persons retainer as director under the Company's 2017 Equity Incentive Plan and exempt from Section 16(b) by virtue of Rule 16(b)-b(d)(1) and (3). The 1,600,000 RSU's are reportable, however, as directly owned shares of common stock, rather as a derivative security in Table II, because any and all underlying RSUs are payable, at such time as they are to be settled, solely in common stock. See Lincoln National Corp. (March 20, 1992) (Q.3).
- [F2]The options vest in four (4) equal annual installments on each anniversary of the grant date, beginning on May 24, 2023.